Estrogen positive breast cancers are currently treated with three types of agents: selective estrogen receptor modulators (tamoxifen), estrogen synthesis inhibitors (aromatase inhibitors) and selective estrogen receptor down-regulators (fulvestrant) [167]. The gene discussed is ESR1; the disease is breast cancer.